175 related articles for article (PubMed ID: 9284751)
1. Methimazole and propylthiouracil equally cross the perfused human term placental lobule.
Mortimer RH; Cannell GR; Addison RS; Johnson LP; Roberts MS; Bernus I
J Clin Endocrinol Metab; 1997 Sep; 82(9):3099-102. PubMed ID: 9284751
[TBL] [Abstract][Full Text] [Related]
2. The placental transfer of propylthiouracil, methimazole and carbimazole.
Marchant B; Brownlie BE; Hart DM; Horton PW; Alexander WD
J Clin Endocrinol Metab; 1977 Dec; 45(6):1187-93. PubMed ID: 591614
[TBL] [Abstract][Full Text] [Related]
3. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
Momotani N; Noh JY; Ishikawa N; Ito K
J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
[TBL] [Abstract][Full Text] [Related]
4. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of developmental toxicity of propylthiouracil and methimazole.
Mallela MK; Strobl M; Poulsen RR; Wendler CC; Booth CJ; Rivkees SA
Birth Defects Res B Dev Reprod Toxicol; 2014 Aug; 101(4):300-7. PubMed ID: 24980470
[TBL] [Abstract][Full Text] [Related]
6. Management of hyperthyroidism during pregnancy and lactation.
Azizi F; Amouzegar A
Eur J Endocrinol; 2011 Jun; 164(6):871-6. PubMed ID: 21389085
[TBL] [Abstract][Full Text] [Related]
7. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
Andersen SL; Olsen J; Wu CS; Laurberg P
J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
[TBL] [Abstract][Full Text] [Related]
8. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
Hackmon R; Blichowski M; Koren G
J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
[TBL] [Abstract][Full Text] [Related]
9. Malformations following methimazole exposure in utero: an open issue.
Ferraris S; Valenzise M; Lerone M; Divizia MT; Rosaia L; Blaid D; Nemelka O; Ferrero GB; Silengo M
Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):989-92. PubMed ID: 14745920
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
[TBL] [Abstract][Full Text] [Related]
11. Toxicities associated with 1-month treatment with propylthiouracil (PTU) and methimazole (MMI) in male rats.
Nambiar PR; Palanisamy GS; Okerberg C; Wolford A; Walters K; Buckbinder L; Reagan WJ
Toxicol Pathol; 2014 Aug; 42(6):970-83. PubMed ID: 24067673
[TBL] [Abstract][Full Text] [Related]
12. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
[TBL] [Abstract][Full Text] [Related]
13. Maternal transfer of methimazole and effects on thyroid hormone availability in embryonic tissues.
Van Herck SL; Geysens S; Bald E; Chwatko G; Delezie E; Dianati E; Ahmed RG; Darras VM
J Endocrinol; 2013 Jul; 218(1):105-15. PubMed ID: 23608220
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring of antithyroid drugs in pregnancy: the knowledge gaps.
Koren G; Soldin O
Ther Drug Monit; 2006 Feb; 28(1):12-3. PubMed ID: 16418686
[TBL] [Abstract][Full Text] [Related]
15. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of thioureylene antithyroid drugs: factors affecting intrathyroidal metabolism of propylthiouracil and methimazole in rats.
Nakashima T; Taurog A; Riesco G
Endocrinology; 1978 Dec; 103(6):2187-97. PubMed ID: 748042
[TBL] [Abstract][Full Text] [Related]
17. Secretion and transfer of the thyroid hormone binding protein transthyretin by human placenta.
Mortimer RH; Landers KA; Balakrishnan B; Li H; Mitchell MD; Patel J; Richard K
Placenta; 2012 Apr; 33(4):252-6. PubMed ID: 22264585
[TBL] [Abstract][Full Text] [Related]
18. Interaction of antithyroid drugs with bovine serum albumin: electrophoretic and fluorimetric study.
Chernov'yants MS; Dolinkin AO; Chernyshev AV; Khohlov EV; Golovanova EG
J Pharm Sci; 2010 Mar; 99(3):1567-73. PubMed ID: 19774650
[TBL] [Abstract][Full Text] [Related]
19. Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
Azizi F; Khoshniat M; Bahrainian M; Hedayati M
J Clin Endocrinol Metab; 2000 Sep; 85(9):3233-8. PubMed ID: 10999814
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
Shiroozu A; Taurog A; Engler H; Dorris ML
Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
